For example, doxorubicin was demonstrated to promote so-called “immunogenic cell death” by inducing the translocation of the endoplasmatic reticulum protein calreticulin (CRT) to the surface of dying CT26 colon carcinoma cells, thus favouring phagocytosis by DCs [16]. Here, CALR is linked to colon carcinoma.